A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)
Clinical trial NCT05186051 · COMPLETED
Trial details
- NCT number
- NCT05186051
- Sponsor
- Zydus Lifesciences Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2022-07-02
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.